Učitavanje...
Effect of carvedilol on atrial excitation-contraction coupling, Ca(2+) release, and arrhythmogenicity
Carvedilol is an FDA-approved β-blocker commonly used for treatment of high blood pressure, congestive heart failure, and cardiac tachyarrhythmias, including atrial fibrillation. We investigated at the cellular level the mechanisms through which carvedilol interferes with sarcoplasmic reticulum (SR)...
Spremljeno u:
| Izdano u: | Am J Physiol Heart Circ Physiol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Physiological Society
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395480/ https://ncbi.nlm.nih.gov/pubmed/32275472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00650.2019 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|